missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mammaglobin A, Mouse anti-Human, Clone: SPM518, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP2-79729-100UG
This item is not returnable.
View return policy
Description
Mammaglobin A Monoclonal specifically detects Mammaglobin A in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Protein Array.
Specifications
| Mammaglobin A | |
| Monoclonal | |
| 0.2 mg/mL | |
| Western Blot 1-2 ug/ml, Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array | |
| Q13296 | |
| SCGB2A2 | |
| Recombinant full-length human Mammaglobin A protein | |
| 100 μg | |
| Primary | |
| Mammaglobin A is a 93 amino acid glycoprotein with homology to other secretoglobin-uteroglobin family members. It was originally identified as a breast cancer restricted biomarker by differential screening. Mammaglobin related to secretoglobin family that includes human uteroglobin and lipophilin. Mammaglobin A antibody stains cytoplasm of normal breast epithelial cells as well as primary and metastatic breast carcinomas. Mammaglobin expression is absent in prostate, kidney, colon, rectum, small intestine, stomach, pancreas, lung, and thyroid tissues. Mammaglobin may be used as part of an immunohistochemical panel for determination of metastatic breast carcinoma and tumor of unknown primary origin. | |
| Store at 4°C. | |
| IgG1 κ |
| Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array | |
| SPM518 | |
| Unconjugated | |
| 10 mM PBS with 0.05% BSA | |
| mammaglobin 1, mammaglobin A, Mammaglobin-1, MGB1mammaglobin-A, MGC71974, Secretoglobin family 2A member 2, secretoglobin, family 2A, member 2, UGB2mammaglobin-1 | |
| Mouse | |
| Protein A or G purified | |
| RUO | |
| 4250 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction